Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

A major change to her prescription benefits meant the medication she was using to manage her weight – a treatment that had ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

For reference, Novo Nordisk also offers a highly successful weight loss drug, Wegovy, a GLP-1 receptor agonist.

Johnna Byrd began taking Zepbound to help her finish the weight loss journey she started. She never imagined it would help ...

How does Innovent Biologics' mazdutide, a groundbreaking dual GLP-1/glucagon receptor drug just approved in China, compared to Wegovy and Zepbound? Read more here.

The effect of Novo Nordisk’s amycretin injections on body weight showed no signs of plateauing after 36 weeks, suggesting the ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy.

INDIANAPOLIS, Ind. - Eli Lilly and Company, a major pharmaceutical company, announced on Monday that its weight-loss drug, Zepbound, will soon be cheaper for people who pay for it themselves, without ...